ranolazine has been researched along with Ache in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bodemer, C; Chaumon, S; Greco, C; Viallard, ML | 1 |
| Agriesti, J; Bartlett, A; David Arnold, W; Freimer, M; Hawash, AA; Kissel, JT; Kline, D; Lorusso, S; Rich, MM | 1 |
2 other study(ies) available for ranolazine and Ache
| Article | Year |
|---|---|
Reduction in pain following treatment with ranolazine in primary erythromelalgia: a case report.
Topics: Erythromelalgia; Gain of Function Mutation; Humans; Male; NAV1.7 Voltage-Gated Sodium Channel; Pain; Pain Management; Pain Measurement; Ranolazine; Sodium Channel Blockers; Treatment Outcome | 2018 |
Open-label trial of ranolazine for the treatment of paramyotonia congenita.
Topics: Adult; Electromyography; Female; Hand Strength; Humans; Male; Middle Aged; Muscle Weakness; Myotonic Disorders; Pain; Ranolazine; Severity of Illness Index; Sodium Channel Blockers; Stiff-Person Syndrome | 2019 |